Warberg Asset Management’s Humacyte Inc Warrant HUMAW Stock Holding History
Bought
Maintained
Sold
Other funds holding HUMAW
CH
LP
ICM
HF
SCM
AGM
EAM
DCP
Warberg Asset Management's HUMAW Position: Q4 2021 in Review
Warberg Asset Management sold out of Humacyte Inc Warrant (HUMAW) in Q4 2021, closing a stake of 35,662 shares — an estimated $103K sold.
Warberg Asset Management first reported a position in HUMAW in Q3 2021 and held it in 1 quarter. The position peaked at $103K in Q3 2021. 15 funds tracked by Wall St. Rank hold HUMAW as of Q4 2021.
- Warberg Asset Management reported no remaining Humacyte Inc Warrant position as of Q4 2021 after selling out during the quarter.
- Warberg Asset Management sold 35,662 Humacyte Inc Warrant shares in Q4 2021, an estimated $103K.
- Warberg Asset Management first reported a position in Humacyte Inc Warrant in Q3 2021 and held it in 1 quarter.
- Warberg Asset Management's Humacyte Inc Warrant position peaked at $103K in Q3 2021.
- 15 funds tracked by Wall St. Rank held Humacyte Inc Warrant as of Q4 2021.
Based on Warberg Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.